These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24852732)

  • 21. Inadequate prescription of chronic consumption of proton pump inhibitors in a hospital in Mexico. Cross-sectional study.
    Sánchez-Cuén JA; Irineo-Cabrales AB; Bernal-Magaña G; Peraza-Garay Fde J
    Rev Esp Enferm Dig; 2013 Mar; 105(3):131-6. PubMed ID: 23735019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department.
    Bez C; Perrottet N; Zingg T; Leung Ki EL; Demartines N; Pannatier A
    J Eval Clin Pract; 2013 Apr; 19(2):374-8. PubMed ID: 22420909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit.
    Masood U; Sharma A; Bhatti Z; Carroll J; Bhardwaj A; Sivalingam D; Dhamoon AS
    Inquiry; 2018; 55():46958018759116. PubMed ID: 29502481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal models of gastric bleeding induced by dual antiplatelet therapy using aspirin and clopidogrel--prophylactic effect of antiulcer drugs.
    Takeuchi K; Izuhara C; Takayama S; Momode T; Kojo M; Hara D; Amagase K
    Curr Pharm Des; 2014; 20(7):1139-48. PubMed ID: 23782140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prescription patterns for antilipidemic drugs in a group of Colombian patients].
    Machado JE; Moncada JC; Mesa G
    Rev Panam Salud Publica; 2008 Mar; 23(3):179-87. PubMed ID: 18397584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison.
    Yu SY; Lee B; McGuire TM; Lee HJ; Hollingworth SA
    Eur J Clin Pharmacol; 2020 Apr; 76(4):547-555. PubMed ID: 31822956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.
    Barozzi N; Tett SE
    Clin Ther; 2009 Apr; 31(4):849-61. PubMed ID: 19446158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?
    Lenoir C; El Biali M; Luthy C; Grosgurin O; Desmeules JA; Rollason V
    Int J Clin Pharm; 2019 Dec; 41(6):1634-1641. PubMed ID: 31664687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress ulcer prophylaxis in hospitalized patients not in intensive care units.
    Grube RR; May DB
    Am J Health Syst Pharm; 2007 Jul; 64(13):1396-400. PubMed ID: 17592004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inappropriate use of proton pump inhibitors during admission and after discharge: a prospective cross-sectional study.
    Sattayalertyanyong O; Thitilertdecha P; Auesomwang C
    Int J Clin Pharm; 2020 Feb; 42(1):174-183. PubMed ID: 31865594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
    El-Serag HB; Fitzgerald S; Richardson P
    Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influential factors in the quality of prescription in primary care and relation to pharmaceutical expenditure].
    Martínez-Gorostiaga J; Echevarría-Orella E; Calvo-Hernáez B
    Rev Esp Salud Publica; 2019 Aug; 93():. PubMed ID: 31378781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
    Hong MT; Monye LC; Seifert CF
    Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study.
    Carvajal A; Arias LH; Vega E; Sánchez JA; Rodríguez IM; Ortega PG; del Pozo JG
    Eur J Clin Pharmacol; 2004 Aug; 60(6):439-44. PubMed ID: 15221157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs.
    Dhippayom T; Walker R
    Pharm World Sci; 2006 Aug; 28(4):194-8. PubMed ID: 17066243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appropriateness of Acid Suppression Therapy.
    De Rijdt T; Spriet I; Willems L; Blanckaert M; Hiele M; Wilmer A; Simoens S
    Ann Pharmacother; 2017 Feb; 51(2):125-134. PubMed ID: 27650819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors: a survey of prescribing in an Irish general hospital.
    Mat Saad AZ; Collins N; Lobo MM; O'Connor HJ
    Int J Clin Pract; 2005 Jan; 59(1):31-4. PubMed ID: 15707461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National survey of stress ulcer prophylaxis.
    Lam NP; Lê PD; Crawford SY; Patel S
    Crit Care Med; 1999 Jan; 27(1):98-103. PubMed ID: 9934901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of gastrointestinal bleeding due to stress ulceration: a review of current literature.
    Pilkington KB; Wagstaff MJ; Greenwood JE
    Anaesth Intensive Care; 2012 Mar; 40(2):253-9. PubMed ID: 22417019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications.
    Orsini JA; Haddock M; Stine L; Sullivan EK; Rabuffo TS; Smith G
    J Am Vet Med Assoc; 2003 Aug; 223(3):336-9. PubMed ID: 12906229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.